Loading...
Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia
BACKGROUND: The calcineurin (CaN) inhibitor, tacrolimus, is widely used in patients undergoing allogeneic organ transplantation and in those with certain allergic diseases. Recently, several reports have suggested that CaN is also associated with schizophrenia. However, little data are currently ava...
Saved in:
| Published in: | Neuropsychiatr Dis Treat |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4940021/ https://ncbi.nlm.nih.gov/pubmed/27462157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S106371 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|